MARIETTA L LARIOSA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry SPOKANE, WA NPI 1689656282
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry WA Teva Pharmaceuticals USA, Inc. All categories
General Payments — all program years on this page
$3,171.55
- Category: General Payments
- Program years: PY2018–2024
- Record count: 66
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $516.62 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $516.62 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $152.28 | 2 |
| Otsuka America Pharmaceutical, Inc. | $147.19 | 2 |
| ABBVIE INC. | $104.84 | 1 |
| ITI, Inc. | $95.75 | 1 |
| Janssen Pharmaceuticals, Inc | $16.56 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078246327 | Janssen Pharmaceuticals, Inc | $16.56 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104138516 | ABBVIE INC. | $104.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118928085 | Otsuka America Pharmaceutical, Inc. | $22.20 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118928087 | Otsuka America Pharmaceutical, Inc. | $124.99 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143262843 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $95.75 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151744488 | Teva Pharmaceuticals USA, Inc. | $26.71 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151744550 | Teva Pharmaceuticals USA, Inc. | $125.57 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.